active surveillance – when can you continue watching and when do you intervene?
Published 2 years ago • 3.7K plays • Length 34:00Download video MP4
Download video MP3
Similar videos
-
1:58
integrated diagnostics and patient selection for active surveillance and treatment
-
20:23
active surveillance criteria and follow-up protocol
-
24:04
active surveillance or focal therapy as primary management
-
28:33
active surveillance results and implications of prospective studies
-
16:33
the when and how of post-ablation surveillance
-
18:31
benefits, pitfalls and complications of rectal spacers
-
15:48
active surveillance for prostate cancer
-
20:24
management of small renal tumors: a guidelines based approach
-
2:40
ask the expert: how often should patients on active surveillance be biopsied and imaged?
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
20:50
active surveillance 2021 - from bench to bedside
-
23:37
active surveillance who is the right patient and what is the right protocol
-
1:11:19
webinar: an introduction to active surveillance
-
20:44
active surveillance 2021 (part 3) - patient selection, monitoring, and innocuous interventions
-
9:15
point-counterpoint: active surveillance for intermediate-risk prostate cancer - pro
-
9:59
point-counterpoint: active surveillance for intermediate-risk prostate cancer - con
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
26:28
active surveillance from biology to bedside
-
4:47
active surveillance for prostate cancer - what you need to know - dr. sanjay razdan
-
18:14
active surveillance: intermediate disease and high-volume grade group 1 prostate cancer
-
14:29
active surveillance at johns hopkins: update 2015
-
7:46
active surveillance 101 | ask a prostate expert, mark scholz, md